New Drugs FDA Approves Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for Subcutaneous Use in Generalized Myasthenia Gravis 2 years ago
New Drugs Pfizer’s Talzenna (talazoparib) in Combination with Xtandi (enzalutamide) Receives U.S. FDA Approval for HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer 2 years ago
New Drugs FDA Approves Jesduvroq (daprodustat) for Anemia Caused by Chronic Kidney Disease for Adults on Dialysis 2 years ago
New Drugs FDA Approves Orserdu (elacestrant) for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer 2 years ago
New Drugs FDA Approves Jaypirca (pirtobrutinib) for Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma 2 years ago
New Drugs FDA Approves Brenzavvy (bexagliflozin) for the Treatment of Adults with Type 2 Diabetes 2 years ago
New Drugs Seagen Announces FDA Accelerated Approval of Tukysa (tucatinib) in Combination with Trastuzumab for People with Previously Treated RAS Wild-Type, HER2-Positive Metastatic Colorectal Cancer 2 years ago
New Drugs FDA Approves Adacel for Immunization During Pregnancy to Help Protect Young Infants Against Pertussis 2 years ago